Print Page
Download PDFCardiac
Suitable for a wide variety of complex congenital heart defects, as well as for adults with extensive valvular disease. The CardioGRAFT® line of tissue grafts offers heart valves, repair grafts, conduits and decellularized tissue grafts with Matracell® decellularization technology.
To download or print our Corporate Brochure click here.
To download or print our Matracell® Brochure click here.
Visit our booth at AATS to learn more about why The Choice is Natural when treating Infective Endocarditis.
Cardiac
CardioGRAFT® Aortic Heart Valve
- No anticoagulation therapy required
- Exceptionally good hemodynamic performance
- No immunosuppressive therapy needed
- Non-thrombogenic
- Non-hemolytic
- Human tissue - most closely resembles native tissue
- High resistance to infection
- Left side/aortic reconstruction
- Aortic stenosis/atresia
- Hypoplastic left heart
- Repair of RVOTs (Right Ventricular Outflow Tract)
| Cryopreserved | Description | Size |
|---|---|---|
| HVA-S | Aortic Heart Valve | D ≤ 16 mm |
| HVA-M | Aortic Heart Valve | D = 17 - 21 mm |
| HVA-L | Aortic Heart Valve | D ≥ 22 mm |
CardioGRAFT® Pulmonary Heart Valve
- No Anticoagulation therapy required
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
- Right side/pulmonary reconstructions
- Hypoplastic left heart (modified Fontan)
- Ross procedure
- Truncus arteriosus
- Pulmonary atresia
- Single ventricle/double outlet (Fontan)
- Pulmonary root stenosis
| Cryopreserved | Description | Size |
|---|---|---|
| HVP-S | Pulmonary Heart Valve | D ≤ 16 mm |
| HVP-M | Pulmonary Heart Valve | D = 17 - 21 mm |
| HVP-L | Pulmonary Heart Valve | D ≥ 22 mm |
CardioGRAFT® Ascending Aorta non-valved
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
- No anticoagulation therapy required
- Conduit repair
| Cryopreserved | Description | Size |
|---|---|---|
| AAS | Ascending Aorta (non-valved) | D ≤ 16 mm |
| AAM | Ascending Aorta (non-valved) | D = 17 - 21 mm |
| AAL | Ascending Aorta (non-valved) | D ≥ 22 mm |
CardioGRAFT® Pulmonary Artery (non valved)
- No Anticoagulation therapy required
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
- Right side/pulmonary reconstructions
- Tetralogy of Fallot
- Pulmonary atresia
- Single ventricle/double outlet (Fontan)
- Truncus arteriosus
- Pulmonary root stenosis
| Cryopreserved | Description | Size |
|---|---|---|
| PAS | Pulmonary Artery (non-valved) | D ≤ 16 mm |
| PAM | Pulmonary Artery (non-valved) | D = 17 - 21 mm |
| PAL | Pulmonary Artery (non-valved) | D ≥ 22 mm |
CardioGRAFT® Thoracic Aorta
- No Anticoagulation therapy required
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
- Infected descending aorta
- Conduit repair
- Extra-cardiac shunt
| Cryopreserved | Description | Size |
|---|---|---|
| TAS | Thoracic Aorta | D ≤ 16 mm |
| TAM | Thoracic Aorta | D = 17 - 21 mm |
| TAL | Thoracic Aorta | D ≥ 22 mm |
CardioGRAFT® Hemi-Pulmonary Artery
- No Anticoagulation therapy required
- Non-thrombogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
- Tetralogy of Fallot
- Pulmonary atresia
- Single ventricle/double outlet (Fontan)
- Truncus arteriosus
- Transposition of great vessels
- Hypoplastic left heart (modified Fontan)
-
Aortic stenosis/atresia
| Description | Size | |
|---|---|---|
| LHPA | Left Hemi-Pulmonary Artery | Varies |
| RHPA | Right Hemi-Pulmonary Artery | Varies |
CardioGRAFT® Mono Cusp Patch
- Single valved section of main pulmonary trunk
- Original annulus diameter
- Length and width measured in centimeters
- No minimum or maximum width
- Tetralogy of Fallot
- RVOT/root enlargement procedures
| Cryopreserved | Description | Size |
|---|---|---|
| MCPL | Mono Cusp Patch | ≥ 22 mm |
CardioGRAFT® Pulmonary Patch section produced from the main pulmonary artery
- No anticoagulation therapy required
- Non-thromogenic
- Non-hemolytic
- No immunosuppressive therapy required
- Human tissue - most closely resembles native tissue
- High resistance to infection
- Right side/pulmonary reconstructions
- Tetralogy of Fallot
- Single ventricle/double outlet (Fontan)
- Truncus arterious; ASD/VSD repair
| Cryopreserved | Description | Size |
|---|---|---|
| PPGK | Thick (Trunk) | W = 2.5 - 5 cm; L = 3 - 8 cm |
| PPGN | Thin (Branch) | W = 2.5 - 5 cm; L = 3 - 8 cm |
CardioGRAFT® Decellularized Pulmonary Patch with Matracell®
- RVOT Repair
| Frozen | Description | Size |
|---|---|---|
| DPPGK | Thick (Trunk) | W = 2.5 - 5 cm; L = 3 - 8 cm |
| DPPGN | Thin (Branch) | W = 2.5 - 5 cm; L = 3 - 8 cm |
CardioGRAFT® Decellularized Hemi-Pulmonary Artery with Matracell®
- Matracell safely removes donor cells and DNA without sacrificing the biomechanical strength of the allograft bio-implant
- RVOT Repair
Decellularized Hemi-Pulmonary Artery with Matracell
| Frozen | Description | Size |
|---|---|---|
| DLHPA | Left | Multiple options, varies by donor |
| DRHPA | Right | Multiple options, varies by donor |